Inventor · disambiguated record
Arban Domi
Also filed as: DOMI ARBAN
16 granted patents·4 pending applications·21 citations·filing 2004–2023
89Inventor score
Top patents by PatentIndex Score
20 records- 0191US11311612B2Compositions and methods for generating an immune response to treat or prevent malariaGEOVAX INC·Filed 2018·Granted Apr 26, 2022·6 cites·17 claims
- 0290US11857611B2Compositions and methods for generating an immune response to treat or prevent malariaGEOVAX INC·Filed 2022·Granted Jan 2, 2024·2 cites·22 claims
- 0385US11278607B2Compositions and methods for generating an immune response to a tumor associated antigenGEOVAX INC·Filed 2017·Granted Mar 22, 2022·2 cites·19 claims
- 0485US9347065B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2013·Granted May 24, 2016·7 cites·4 claims
- 0584US11052148B2Compositions and methods for generating an immune response to hepatitis B virusGEOVAX INC·Filed 2017·Granted Jul 6, 2021·2 cites·11 claims
- 0683US12370249B2Replication-deficient modified vaccinia ankara (MVA) expressing marburg virus glycoprotein (GP) and matrix protein (VP40)GEOVAX INC·Filed 2023·Granted Jul 29, 2025·0 cites·22 claims
- 0782US12329808B2Compositions and methods for generating an immune response to treat or prevent malariaGEOVAX INC·Filed 2023·Granted Jun 17, 2025·0 cites·17 claims
- 0881US11413341B2Vaccinia viral vectors encoding chimeric virus like particlesGEOVAX INC·Filed 2020·Granted Aug 16, 2022·1 cites·14 claims
- 0973US12247214B2Vaccinia viral vectors encoding chimeric virus like particlesGEOVAX INC·Filed 2022·Granted Mar 11, 2025·0 cites·21 claims
- 1073US11896657B2Replication-deficient modified vaccinia Ankara (MVA) expressing Marburg virus glycoprotein (GP) and matrix protein (VP40)GEOVAX INC·Filed 2022·Granted Feb 13, 2024·0 cites·11 claims
- 1169US7494813B2VAC-BAC shuttle vector systemUS HEALTH·Filed 2004·Granted Feb 24, 2009·1 cites·41 claims
- 1268US11801299B2Compositions and methods for generating an immune response to hepatitis B virusUNIV GEORGIA STATE RES FOUND·Filed 2021·Granted Oct 31, 2023·0 cites·15 claims
- 1364US11638750B2Methods for generating a Zikv immune response utilizing a recombinant modified vaccina Ankara vector encoding the NS1 proteinGEOVAX INC·Filed 2020·Granted May 2, 2023·0 cites·22 claims
- 1460US11701418B2Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40)GEOVAX INC·Filed 2016·Granted Jul 18, 2023·0 cites·27 claims
- 1558US2024344082A1Viral constructs for use in enhancing t-cell priming during vaccinationGEOVAX INC·Filed 2023·Application pending·0 cites
- 1657US2022160853A1Cancer vaccine compositions and methods for use thereofGEOVAX INC·Filed 2021·Application pending·0 cites
- 1753US9944935B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Apr 17, 2018·0 cites·11 claims
- 1851US2019030157A1Compositions and Methods for Generating an Immune Response to a FlavivirusGEOVAX INC·Filed 2017·Application pending·0 cites
- 1946US2020171141A1Compositions and Methods for Generating an Immune Response to LASVGEOVAX INC·Filed 2018·Application pending·0 cites
- 2045US10081796B2Neutralization-resistant CDV mutants and viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Sep 25, 2018·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Arban Domi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →